益普索（Ipsos）：2025欧洲神经科医师对阿尔茨海默病的见解调研报告（英文版）（14页）.pdf

1、 Ipsos|AD opinions data to accompany press release|September 2025|PublicEUROPEAN NEUROLOGISTS OPINIONS ON ALZHEIMERS DISEASE25-034902September 2025Sample and methodologyNeurologists screened on the following criteria:See a minimum of 5 MCI/early AD patientsAre personally responsible for management a

2、nd treatment decisionsWithin role for 3-30 yearsSpend a minimum of 60%time in clinical practicePractice in relevant clinical settings,of which out-patients are treatedNot affiliated to pharmaceutical or government entitiesNot participated in market research in Alzheimers disease in past monthNeurolo

3、gistsFrance100Germany100Italy100Spain100TOTAL40025-minute online survey3 Ipsos|AD opinions data to accompany press release|September 2025|Public Disclaimer:All data presented in this deck reflects the views of surveyed neurologists(n=400).Statements are based on survey responses and are intended to

4、be factual and non-conclusive.Interpretations should be made in context of the survey design and scope.4 Ipsos|AD opinions data to accompany press release|September 2025|Public How to read this report1Significant differencesAll data has been reviewed to determine statistical significance across coun

5、triesWhere relevant,significance has been shown via if significantly different vs.2 other countries2Full question textThe complete question text can be found within the notes section of each slide.This provides the full question,alongside the full text of any prompted statements3Option of Dont knowA

6、biding by publication requirements and standards,each question included within the survey required a dont know optionData for this variable has been included within the charts to share opinion on the full sample composition5 Ipsos|AD opinions data to accompany press release|September 2025|Public 3%1